Gistera AHG. The immunology of atherosclerosis. Nat. Rev. Nephrol. 2017;13:368–80.
PubMed Article CAS Google Scholar
Khyzha N, Alizada A, Wilson MD, Fish JE. Epigenetics of atherosclerosis: emerging mechanisms and methods. Trends Mol. Med. 2017;23:332–47.
CAS PubMed Article Google Scholar
Zhang BC, Li XK, Che WL, Li WM, Hou L, Wei YD, et al. Peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice. Zhonghua Xin Xue Guan Bing Za Zhi. 2013;41:143–9.
Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–25.
CAS PubMed Article Google Scholar
Riccioni G, Sblendorio V. Atherosclerosis: from biology to pharmacological treatment. J. Geriatr. Cardiol. 2012;9:305–17.
PubMed PubMed Central Article Google Scholar
Charo IF, Taub R. Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat. Rev. Drug Discov. 2011;10:365–76.
CAS PubMed PubMed Central Article Google Scholar
Zeng Y, Song JX, Shen XC. Herbal remedies supply a novel prospect for the treatment of atherosclerosis: a review of current mechanism studies. Phytother. Res. 2012;26:159–67.
CAS PubMed Article Google Scholar
Dong Y, Fernandes C, Liu Y, Wu Y, Wu H, Brophy ML, et al. Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis. Diab. Vasc. Dis. Res. 2017;14:14–23.
CAS PubMed Article Google Scholar
Goodall JCWC, Zhang Y. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc. Natl. Acad. Sci. U. S. A. 2010;107:17698–703.
CAS PubMed PubMed Central Article Google Scholar
H N. CHOP is a multifunctional transcription factor in the ER stress response. J Biochem. 2012;151:217-9.
Ohoka NYS, Hattori T, Onozaki K, Hayashi H. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 2005;24:1243–55.
CAS PubMed PubMed Central Article Google Scholar
Wang ZHSY, Zhang S. Silence of TRIB3 suppresses atherosclerosis and stabilizes plaques in diabetic ApoE-/-/LDL receptor-/- mice. Diabetes. 2012;61:463–73.
CAS PubMed PubMed Central Article Google Scholar
An D, Lessard SJ, Toyoda T, Lee MY, Koh HJ, Qi L, et al. Overexpression of TRB3 in muscle alters muscle fiber type and improves exercise capacity in mice. Am. J. Phys. Regul. Integr. Comp. Phys. 2014;306:R925–33.
Aryal BRN, Fernandez-Hernando C. Noncoding RNAs and atherosclerosis. Curr. Atheroscler. Rep. 2014;16:407.
PubMed PubMed Central Article CAS Google Scholar
OA CDA, Bobryshev YV. Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxford). 2015;214:33–50.
Di Gregoli KMAN, Bianco R. MicroRNA-181b controls atherosclerosis and aneurysms through regulation of TIMP-3 and elastin. Circ. Res. 2017;120:49–65.
PubMed PubMed Central Article CAS Google Scholar
Gorenne I, Kumar S, Gray K, Figg N, Yu H, Mercer J, et al. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis. Circulation. 2013;127:386–96.
CAS PubMed Article Google Scholar
Goikuria H, Freijo MDM, Vega Manrique R, Sastre M, Elizagaray E, Lorenzo A, et al. Characterization of carotid smooth muscle cells during phenotypic transition. Cells. 2018;7.
Jiang LQY, Wang Z, Ma X, Wang H, Li J. Inhibition of microRNA-103 attenuates inflammation and endoplasmic reticulum stress in atherosclerosis through disrupting the PTEN-mediated MAPK signaling. J. Cell. Physiol. 2020;235:380–93.
CAS PubMed Article Google Scholar
Huang SC, Wang M, Wu WB, Wang R, Cui J, Li W, et al. Mir-22-3p inhibits arterial smooth muscle cell proliferation and migration and neointimal hyperplasia by targeting HMGB1 in arteriosclerosis obliterans. Cell. Physiol. Biochem. 2017;42:2492–506.
CAS PubMed Article Google Scholar
Wang JPY, Zhong Y, Jiang S, Shao J, Gong J. Altered serum microRNAs as novel diagnostic biomarkers for atypical coronary artery disease. PLoS One. 2014;9:e107012.
PubMed PubMed Central Article CAS Google Scholar
Cardellini MMR, Martelli E. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes. 2009;58:2396–401.
CAS PubMed PubMed Central Article Google Scholar
Menghini R, Menini S, Amoruso R, Fiorentino L, Casagrande V, Marzano V, et al. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology. 2009;136:663–72 e4.
CAS PubMed Article Google Scholar
Stohr R, Kappel BA, Carnevale D, Cavalera M, Mavilio M, Arisi I, et al. TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice. Mol Metab. 2015;4:741–52.
CAS PubMed PubMed Central Article Google Scholar
Liu P, Su J, Song X, Wang S. miR-92a regulates the expression levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 3 via sirtuin 1 signaling in hydrogen peroxide-induced vascular smooth muscle cells. Mol Med Rep. 2018;17:1041–8.
English WR, Ireland-Zecchini H, Baker AH, Littlewood TD, Bennett MR, Murphy G. Tissue inhibitor of metalloproteinase-3 (TIMP-3) induces FAS dependent apoptosis in human vascular smooth muscle cells. PLoS One. 2018;13:e0195116.
PubMed PubMed Central Article CAS Google Scholar
Xu Y, Bei Y, Shen S, Zhang J, Lu Y, Xiao J, et al. MicroRNA-222 Promotes the proliferation of pulmonary arterial smooth muscle cells by targeting P27 and TIMP3. Cell. Physiol. Biochem. 2017;43:282–92.
CAS PubMed Article Google Scholar
Xu SPJ, Jin ZG. Atherosclerosis is an epigenetic disease. Trends Endocrinol. Metab. 2018;29:739–42.
CAS PubMed PubMed Central Article Google Scholar
Churov A, Summerhill V, Grechko A, Orekhova V, Orekhov A. MicroRNAs as Potential Biomarkers in Atherosclerosis. Int J Mol Sci. 2019;20:5547.
CAS PubMed Central Article Google Scholar
Papageorgiou N, Tousoulis D, Androulakis E, Kontogeorgou A, Charakida M, Giolis A, et al. The role of microRNAs in the initiation and progression of stable atheromatous plaque. Curr. Pharm. Des. 2013;19:1651–7.
Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen RR, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J. Clin. Invest. 2012;122:4190–202.
CAS PubMed PubMed Central Article Google Scholar
Horie TBO, Kuwabara Y. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice. J. Am. Heart Assoc. 2012;1:e003376.
PubMed PubMed Central Article CAS Google Scholar
Zhang Y, Wang Y, Wang X, Zhang Y, Eisner GM, Asico LD, et al. Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J. Hypertens. 2011;29:1560–8.
CAS PubMed Article Google Scholar
Lu TX, Rothenberg ME. MicroRNA. J. Allergy Clin. Immunol. 2018;141:1202–7.
CAS PubMed Article Google Scholar
Fu X, Zeng L, Liu Z, Ke X, Lei L, Li G. MicroRNA-206 regulates the secretion of inflammatory cytokines and MMP9 expression by targeting TIMP3 in Mycobacterium tuberculosis-infected THP-1 human macrophages. Biochem. Biophys. Res. Commun. 2016;477:167–73.
CAS PubMed Article Google Scholar
Di Gregoli K, Mohamad Anuar NN, Bianco R, White SJ, Newby AC, George SJ, et al. MicroRNA-181b controls atherosclerosis and aneurysms through regulation of TIMP-3 and elastin. Circ. Res. 2017;120:49–65.
PubMed PubMed Central Article CAS Google Scholar
Cardellini M, Menghini R, Martelli E, Casagrande V, Marino A, Rizza S, et al. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes. 2009;58:2396–401.
CAS PubMed PubMed Central Article Google Scholar
Son DJJY, Seo YS. Interleukin-32alpha inhibits endothelial inflammation, vascular smooth muscle cell activation, and atherosclerosis by upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis. Theranostics. 2017;7:2186–203.
留言 (0)